Professor Alan North - Audio

Professor Alan North - Audio

By UCL
Download on the App Store

All Professor Alan North - Audio episodes

  • 1. Whether to study physics or medicine
    Professor Alan North grew up in West Yorkshire and studied medicine at the University of Aberdeen before taking a PhD in pharmacology (1973). He moved to the US in 1975 as Associate Professor of Pharmacology at Loyola University Stritch School of Medicine, before becoming Professor of Neuropharmacology at the Massachusetts Institute of Technology, and Senior Scientist and Professor at the Vollum Institute of Oregon Health Sciences University, Portland. In 1993, he was appointed Principal Scientist at the Glaxo Institute for Molecular Biology, Geneva, and returned to England in 1998 as Professor of Molecular Physiology at the University of Sheffield, and Director of its Institute of Molecular Physiology.
    Professor North’s work has focused on a quantitative understanding of drug and transmitter action at the level of single cells and single molecules, primarily by biophysical and molecular biological approaches. His extensive publications deal with drug and neurotransmitter receptors, structure and function of ion channels, the physiology of the autonomic (particularly enteric) nervous system, pain mechanisms, psychoactive drugs and mental illness. He has served as editor of the Journal of Physiology, the Journal of Neuroscience, and Molecular Pharmacology. He has been Editor-in-Chief of the British Journal of Pharmacology (2000-2004), President of the Physiological Society (2003-2006), and a member of the Medical Research Council (2001-2006). He was elected Fellow of the Royal Society of London (1995).
    Professor North is Vice-President of the University of Manchester. He serves as Dean of the Faculty of Life Sciences (from July 2004) and Dean of the Faculty of Medical and Human Sciences (from July 2006).
    3 min
  • 15. Glaxo Institute for Molecular Biology, Geneva: two P2X receptors discovered
    Professor Alan North grew up in West Yorkshire and studied medicine at the University of Aberdeen before taking a PhD in pharmacology (1973). He moved to the US in 1975 as Associate Professor of Pharmacology at Loyola University Stritch School of Medicine, before becoming Professor of Neuropharmacology at the Massachusetts Institute of Technology, and Senior Scientist and Professor at the Vollum Institute of Oregon Health Sciences University, Portland. In 1993, he was appointed Principal Scientist at the Glaxo Institute for Molecular Biology, Geneva, and returned to England in 1998 as Professor of Molecular Physiology at the University of Sheffield, and Director of its Institute of Molecular Physiology.
    Professor North’s work has focused on a quantitative understanding of drug and transmitter action at the level of single cells and single molecules, primarily by biophysical and molecular biological approaches. His extensive publications deal with drug and neurotransmitter receptors, structure and function of ion channels, the physiology of the autonomic (particularly enteric) nervous system, pain mechanisms, psychoactive drugs and mental illness. He has served as editor of the Journal of Physiology, the Journal of Neuroscience, and Molecular Pharmacology. He has been Editor-in-Chief of the British Journal of Pharmacology (2000-2004), President of the Physiological Society (2003-2006), and a member of the Medical Research Council (2001-2006). He was elected Fellow of the Royal Society of London (1995).
    Professor North is Vice-President of the University of Manchester. He serves as Dean of the Faculty of Life Sciences (from July 2004) and Dean of the Faculty of Medical and Human Sciences (from July 2006).
    5 min
  • 14. Therapeutic potential of blocking and unblocking potassium channels
    Professor Alan North grew up in West Yorkshire and studied medicine at the University of Aberdeen before taking a PhD in pharmacology (1973). He moved to the US in 1975 as Associate Professor of Pharmacology at Loyola University Stritch School of Medicine, before becoming Professor of Neuropharmacology at the Massachusetts Institute of Technology, and Senior Scientist and Professor at the Vollum Institute of Oregon Health Sciences University, Portland. In 1993, he was appointed Principal Scientist at the Glaxo Institute for Molecular Biology, Geneva, and returned to England in 1998 as Professor of Molecular Physiology at the University of Sheffield, and Director of its Institute of Molecular Physiology.
    Professor North’s work has focused on a quantitative understanding of drug and transmitter action at the level of single cells and single molecules, primarily by biophysical and molecular biological approaches. His extensive publications deal with drug and neurotransmitter receptors, structure and function of ion channels, the physiology of the autonomic (particularly enteric) nervous system, pain mechanisms, psychoactive drugs and mental illness. He has served as editor of the Journal of Physiology, the Journal of Neuroscience, and Molecular Pharmacology. He has been Editor-in-Chief of the British Journal of Pharmacology (2000-2004), President of the Physiological Society (2003-2006), and a member of the Medical Research Council (2001-2006). He was elected Fellow of the Royal Society of London (1995).
    Professor North is Vice-President of the University of Manchester. He serves as Dean of the Faculty of Life Sciences (from July 2004) and Dean of the Faculty of Medical and Human Sciences (from July 2006).
    3 min
  • 10. Vollum Institute, Portland, Oregon - molecular physiology: classifying nerve cells
    Professor Alan North grew up in West Yorkshire and studied medicine at the University of Aberdeen before taking a PhD in pharmacology (1973). He moved to the US in 1975 as Associate Professor of Pharmacology at Loyola University Stritch School of Medicine, before becoming Professor of Neuropharmacology at the Massachusetts Institute of Technology, and Senior Scientist and Professor at the Vollum Institute of Oregon Health Sciences University, Portland. In 1993, he was appointed Principal Scientist at the Glaxo Institute for Molecular Biology, Geneva, and returned to England in 1998 as Professor of Molecular Physiology at the University of Sheffield, and Director of its Institute of Molecular Physiology.
    Professor North’s work has focused on a quantitative understanding of drug and transmitter action at the level of single cells and single molecules, primarily by biophysical and molecular biological approaches. His extensive publications deal with drug and neurotransmitter receptors, structure and function of ion channels, the physiology of the autonomic (particularly enteric) nervous system, pain mechanisms, psychoactive drugs and mental illness. He has served as editor of the Journal of Physiology, the Journal of Neuroscience, and Molecular Pharmacology. He has been Editor-in-Chief of the British Journal of Pharmacology (2000-2004), President of the Physiological Society (2003-2006), and a member of the Medical Research Council (2001-2006). He was elected Fellow of the Royal Society of London (1995).
    Professor North is Vice-President of the University of Manchester. He serves as Dean of the Faculty of Life Sciences (from July 2004) and Dean of the Faculty of Medical and Human Sciences (from July 2006).
    2 min
  • 7. Massachusetts Institute of Technology: disbelief at our studies of the spinal cord
    Professor Alan North grew up in West Yorkshire and studied medicine at the University of Aberdeen before taking a PhD in pharmacology (1973). He moved to the US in 1975 as Associate Professor of Pharmacology at Loyola University Stritch School of Medicine, before becoming Professor of Neuropharmacology at the Massachusetts Institute of Technology, and Senior Scientist and Professor at the Vollum Institute of Oregon Health Sciences University, Portland. In 1993, he was appointed Principal Scientist at the Glaxo Institute for Molecular Biology, Geneva, and returned to England in 1998 as Professor of Molecular Physiology at the University of Sheffield, and Director of its Institute of Molecular Physiology.
    Professor North’s work has focused on a quantitative understanding of drug and transmitter action at the level of single cells and single molecules, primarily by biophysical and molecular biological approaches. His extensive publications deal with drug and neurotransmitter receptors, structure and function of ion channels, the physiology of the autonomic (particularly enteric) nervous system, pain mechanisms, psychoactive drugs and mental illness. He has served as editor of the Journal of Physiology, the Journal of Neuroscience, and Molecular Pharmacology. He has been Editor-in-Chief of the British Journal of Pharmacology (2000-2004), President of the Physiological Society (2003-2006), and a member of the Medical Research Council (2001-2006). He was elected Fellow of the Royal Society of London (1995).
    Professor North is Vice-President of the University of Manchester. He serves as Dean of the Faculty of Life Sciences (from July 2004) and Dean of the Faculty of Medical and Human Sciences (from July 2006).
    3 min
  • 4. Loyola School of Medicine, Illinois, and electrophysiology how opiates act on single
    Professor Alan North grew up in West Yorkshire and studied medicine at the University of Aberdeen before taking a PhD in pharmacology (1973). He moved to the US in 1975 as Associate Professor of Pharmacology at Loyola University Stritch School of Medicine, before becoming Professor of Neuropharmacology at the Massachusetts Institute of Technology, and Senior Scientist and Professor at the Vollum Institute of Oregon Health Sciences University, Portland. In 1993, he was appointed Principal Scientist at the Glaxo Institute for Molecular Biology, Geneva, and returned to England in 1998 as Professor of Molecular Physiology at the University of Sheffield, and Director of its Institute of Molecular Physiology.
    Professor North’s work has focused on a quantitative understanding of drug and transmitter action at the level of single cells and single molecules, primarily by biophysical and molecular biological approaches. His extensive publications deal with drug and neurotransmitter receptors, structure and function of ion channels, the physiology of the autonomic (particularly enteric) nervous system, pain mechanisms, psychoactive drugs and mental illness. He has served as editor of the Journal of Physiology, the Journal of Neuroscience, and Molecular Pharmacology. He has been Editor-in-Chief of the British Journal of Pharmacology (2000-2004), President of the Physiological Society (2003-2006), and a member of the Medical Research Council (2001-2006). He was elected Fellow of the Royal Society of London (1995).
    Professor North is Vice-President of the University of Manchester. He serves as Dean of the Faculty of Life Sciences (from July 2004) and Dean of the Faculty of Medical and Human Sciences (from July 2006).
    3 min
  • 23. PX2 receptors and reverse physiology
    Professor Alan North grew up in West Yorkshire and studied medicine at the University of Aberdeen before taking a PhD in pharmacology (1973). He moved to the US in 1975 as Associate Professor of Pharmacology at Loyola University Stritch School of Medicine, before becoming Professor of Neuropharmacology at the Massachusetts Institute of Technology, and Senior Scientist and Professor at the Vollum Institute of Oregon Health Sciences University, Portland. In 1993, he was appointed Principal Scientist at the Glaxo Institute for Molecular Biology, Geneva, and returned to England in 1998 as Professor of Molecular Physiology at the University of Sheffield, and Director of its Institute of Molecular Physiology.
    Professor North’s work has focused on a quantitative understanding of drug and transmitter action at the level of single cells and single molecules, primarily by biophysical and molecular biological approaches. His extensive publications deal with drug and neurotransmitter receptors, structure and function of ion channels, the physiology of the autonomic (particularly enteric) nervous system, pain mechanisms, psychoactive drugs and mental illness. He has served as editor of the Journal of Physiology, the Journal of Neuroscience, and Molecular Pharmacology. He has been Editor-in-Chief of the British Journal of Pharmacology (2000-2004), President of the Physiological Society (2003-2006), and a member of the Medical Research Council (2001-2006). He was elected Fellow of the Royal Society of London (1995).
    Professor North is Vice-President of the University of Manchester. He serves as Dean of the Faculty of Life Sciences (from July 2004) and Dean of the Faculty of Medical and Human Sciences (from July 2006).
    4 min
  • 22. The role of ATP receptor
    Professor Alan North grew up in West Yorkshire and studied medicine at the University of Aberdeen before taking a PhD in pharmacology (1973). He moved to the US in 1975 as Associate Professor of Pharmacology at Loyola University Stritch School of Medicine, before becoming Professor of Neuropharmacology at the Massachusetts Institute of Technology, and Senior Scientist and Professor at the Vollum Institute of Oregon Health Sciences University, Portland. In 1993, he was appointed Principal Scientist at the Glaxo Institute for Molecular Biology, Geneva, and returned to England in 1998 as Professor of Molecular Physiology at the University of Sheffield, and Director of its Institute of Molecular Physiology.
    Professor North’s work has focused on a quantitative understanding of drug and transmitter action at the level of single cells and single molecules, primarily by biophysical and molecular biological approaches. His extensive publications deal with drug and neurotransmitter receptors, structure and function of ion channels, the physiology of the autonomic (particularly enteric) nervous system, pain mechanisms, psychoactive drugs and mental illness. He has served as editor of the Journal of Physiology, the Journal of Neuroscience, and Molecular Pharmacology. He has been Editor-in-Chief of the British Journal of Pharmacology (2000-2004), President of the Physiological Society (2003-2006), and a member of the Medical Research Council (2001-2006). He was elected Fellow of the Royal Society of London (1995).
    Professor North is Vice-President of the University of Manchester. He serves as Dean of the Faculty of Life Sciences (from July 2004) and Dean of the Faculty of Medical and Human Sciences (from July 2006).
    3 min
  • 21. Astrocytes and microglia are P2X receptors
    Professor Alan North grew up in West Yorkshire and studied medicine at the University of Aberdeen before taking a PhD in pharmacology (1973). He moved to the US in 1975 as Associate Professor of Pharmacology at Loyola University Stritch School of Medicine, before becoming Professor of Neuropharmacology at the Massachusetts Institute of Technology, and Senior Scientist and Professor at the Vollum Institute of Oregon Health Sciences University, Portland. In 1993, he was appointed Principal Scientist at the Glaxo Institute for Molecular Biology, Geneva, and returned to England in 1998 as Professor of Molecular Physiology at the University of Sheffield, and Director of its Institute of Molecular Physiology.
    Professor North’s work has focused on a quantitative understanding of drug and transmitter action at the level of single cells and single molecules, primarily by biophysical and molecular biological approaches. His extensive publications deal with drug and neurotransmitter receptors, structure and function of ion channels, the physiology of the autonomic (particularly enteric) nervous system, pain mechanisms, psychoactive drugs and mental illness. He has served as editor of the Journal of Physiology, the Journal of Neuroscience, and Molecular Pharmacology. He has been Editor-in-Chief of the British Journal of Pharmacology (2000-2004), President of the Physiological Society (2003-2006), and a member of the Medical Research Council (2001-2006). He was elected Fellow of the Royal Society of London (1995).
    Professor North is Vice-President of the University of Manchester. He serves as Dean of the Faculty of Life Sciences (from July 2004) and Dean of the Faculty of Medical and Human Sciences (from July 2006).
    2 min
  • 20. Exploring P2X4 receptors in the central nervous system
    Professor Alan North grew up in West Yorkshire and studied medicine at the University of Aberdeen before taking a PhD in pharmacology (1973). He moved to the US in 1975 as Associate Professor of Pharmacology at Loyola University Stritch School of Medicine, before becoming Professor of Neuropharmacology at the Massachusetts Institute of Technology, and Senior Scientist and Professor at the Vollum Institute of Oregon Health Sciences University, Portland. In 1993, he was appointed Principal Scientist at the Glaxo Institute for Molecular Biology, Geneva, and returned to England in 1998 as Professor of Molecular Physiology at the University of Sheffield, and Director of its Institute of Molecular Physiology.
    Professor North’s work has focused on a quantitative understanding of drug and transmitter action at the level of single cells and single molecules, primarily by biophysical and molecular biological approaches. His extensive publications deal with drug and neurotransmitter receptors, structure and function of ion channels, the physiology of the autonomic (particularly enteric) nervous system, pain mechanisms, psychoactive drugs and mental illness. He has served as editor of the Journal of Physiology, the Journal of Neuroscience, and Molecular Pharmacology. He has been Editor-in-Chief of the British Journal of Pharmacology (2000-2004), President of the Physiological Society (2003-2006), and a member of the Medical Research Council (2001-2006). He was elected Fellow of the Royal Society of London (1995).
    Professor North is Vice-President of the University of Manchester. He serves as Dean of the Faculty of Life Sciences (from July 2004) and Dean of the Faculty of Medical and Human Sciences (from July 2006).
    0 min